forum for health policy · patient perspectives - patient narratives (cave: blind spot: quality of...

26
Institut für Biomedizinische Ethik und Medizingeschichte The Swiss health care system – features, challenges and opportunities Forum for Health Policy Stockhom, Sweden, 26 September 2017 Prof. Dr. med. Dr. phil. Nikola Biller-Andorno Institute for Biomedical Ethics and History of Medicine, University of Zurich, Switzerland

Upload: others

Post on 17-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

The Swiss health care system – features, challenges and opportunities

Forum for Health Policy Stockhom, Sweden, 26 September 2017

Prof. Dr. med. Dr. phil. Nikola Biller-Andorno Institute for Biomedical Ethics and History of Medicine, University of Zurich, Switzerland

Page 2: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

I. Features

Page 3: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

- Federalism - Direct democracy- Multilingual- International orientation

Page 4: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 5: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 6: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

• Wealthy country

• High life expectancy and quality of life

• Universal access to health care

• Comprehensive health benefit package

• Patient satisfaction with health care

Page 7: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 8: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 9: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Access Solidarity

Choice Personal responsibility

What seems to be working fairly well?

- Mandatory health insurance for a residents in Switzerland

- Universal access to a comprehensive benefit package

- Community rating - Subsidiaries for economically

weaker individiuals

- Insurance market (60+ insurers) > private on-top insurance > comparative platforms > programs/profiles (health competency, fitness apps etc.) - Different insurance models (standard: free choice

of physician, GP, telemedicine, managed care) - Range of annual deductibles (300 – 2500 CHF) - Co-pay (10%) and out-of-pocket expenses

Page 10: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

„the Swiss model provides universal coverage in an insurance premium-funded system characterized by competition between independent insurers, competition between providers, consumer choice of health plan characteristics, and a high level of consumer responsibility.“ 

Page 11: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

II. Challenges

Page 12: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

- Mandatory health insurance for all Swiss residents.

Page 13: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 14: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

2013

Page 15: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

...

Page 16: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Core challenges1. The incidence of chronic diseases will increase > prevention, early detection, health promotion2. The way health care is delivered will have to change > better coordination, use of e-health, patient orientation 3. The financial basis of the continually growing health sector must be safeguarded > exhaust efficiency reserves (avoid duplication of services etc.)4. The lack of manageability and transparency must be eliminated > better data, collaboration between the federal government and cantons

Page 17: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

III. Opportunities

Page 18: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

What might work fairly well Patient empowerment:- information > evidence-based (quantitative and qualitative) > in plain language > unbiased by commerical interests- decision aids- suitable interfaces (EHR)/documentation of preferences

Page 19: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

➢ Actively involve patients ➢ Create a culture that promotes openness and critical reflection ➢ Improve compensation and incentive structures ➢ Improve the existing certification process ➢ Carry out targeted data collection and analysis

Page 20: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 21: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

21

Overdiagnosis/

- treatment

Enable informed choice - Comprehensive information - Fact sheets (for patients AND providers)

- State of the art risk communication - Decision aids

Better understanding of patient perspectives - Patient narratives (cave:

blind spot: quality of indication)

- Quantitative studies of patient expectations/preferences/values

Use of e-health (records) - Patient values in chart - Results of decision aids

as basis for face-to-face consultation

- Online platforms

Provider guidance - Training in

communication/SDM - Clinical practice

guideline reviews/guidelines for guidelines

- Performance indicators (coordination of care, quality of indication)

- Remove dysfunctional incentives

Circulus virtuosus

Page 22: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 23: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

I

Page 24: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Page 25: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Accessibility

Afforda- bility

Choicequality

Trust

Sustaina- bility

Patient orientation

Appropriate care

Patient/ citizen engagement

Regulated competition

Solidarity

Consumer responsibility

Cooperation and integration Population

health needs

Page 26: Forum for Health Policy · patient perspectives - Patient narratives (cave: blind spot: quality of indication) - Quantitative studies of patient expectations/ preferences/values Use

Institut für Biomedizinische Ethik und Medizingeschichte

Thanks for your attention, and...

Prof. Dr. med. Dr. phil. Nikola Biller-Andorno Institute of Biomedical Ethics and History of Medicine

University of Zurich, Switzerland http://www.ibme.uzh.ch

[email protected]

... we are looking forward to

learning from Sweden!